Niki BioSolutions, Inc. (NIKI) Retained Earnings (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Retained Earnings came in at -$6.2 million in Q4 2025, down 2.07% on a QoQ basis from -$6.1 million in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Retained Earnings (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Retained Earnings data on file, last reported at -$6.2 million in Q4 2025.

Quarterly Retained Earnings changed N/A year-over-year to -$6.2 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was -$6.2 million (changed N/A YoY) and the FY2025 annual result came in at $97.0 million, up 3.77% from the prior year.
Retained Earnings eased to -$6.2 million in Q4 2025, from -$6.1 million in the prior quarter.
In the past five years, Retained Earnings ranged from a high of $93.0 million in Q4 2023 to a low of -$65.3 million in Q4 2022.
A 5-year average of -$6.2 million and a median of -$6.2 million in 2025 frame the typical range for Retained Earnings.
Annual changes were most pronounced in 2021 — Retained Earnings sank 245.2% — and 2023, when it jumped 261.33%.
Tracing NIKI's Retained Earnings over 5 years: stood at -$55.5 million in 2021, then retreated by 17.64% to -$65.3 million in 2022, then soared by 242.37% to $93.0 million in 2023, then slumped by 105.46% to -$5.1 million in 2024, then decreased by 22.7% to -$6.2 million in 2025.
The last three Retained Earnings figures came in at -$6.2 million (Q4 2025), -$6.1 million (Q3 2025), and -$5.8 million (Q2 2025), per Business Quant data.

Download Data